 Technology Assessment, Biomedical
"Technology Assessment, Biomedical" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Evaluation of biomedical technology in relation to cost, efficacy, utilization, etc., and its future impact on social, ethical, and legal systems.
| Descriptor ID |
D013673
|
| MeSH Number(s) |
N03.880 N05.715.360.825
|
| Concept/Terms |
Technology Assessment, Biomedical- Technology Assessment, Biomedical
- Biomedical Technology Assessment
- Technology Assessment, Health
- Assessment, Health Technology
- Assessments, Health Technology
- Health Technology Assessment
- Health Technology Assessments
- Technology Assessments, Health
- Assessment, Biomedical Technology
- Assessments, Biomedical Technology
- Biomedical Technology Assessments
- Technology Assessments, Biomedical
Technology Assessment- Technology Assessment
- Assessment, Technology
- Assessments, Technology
- Technology Assessments
|
Below are MeSH descriptors whose meaning is more general than "Technology Assessment, Biomedical".
Below are MeSH descriptors whose meaning is more specific than "Technology Assessment, Biomedical".
This graph shows the total number of publications written about "Technology Assessment, Biomedical" by people in this website by year, and whether "Technology Assessment, Biomedical" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 4 | 4 | | 1997 | 1 | 0 | 1 | | 1998 | 0 | 1 | 1 | | 2005 | 1 | 1 | 2 | | 2007 | 1 | 4 | 5 | | 2008 | 1 | 0 | 1 | | 2010 | 0 | 2 | 2 | | 2013 | 1 | 0 | 1 | | 2014 | 0 | 1 | 1 | | 2015 | 1 | 1 | 2 | | 2016 | 1 | 1 | 2 | | 2019 | 1 | 0 | 1 | | 2022 | 1 | 0 | 1 | | 2023 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Technology Assessment, Biomedical" by people in Profiles.
-
DiStefano MJ, Karim SA, Krubiner CB, Hofman KJ. Integrating Health Technology Assessment and the Right to Health in South Africa: A Qualitative Content Analysis of Substantive Values in Landmark Judicial Decisions. J Law Med Ethics. 2023; 51(1):131-149.
-
Mendola ND, Oehrlein E, Perfetto EM, Westrich K, McQueen RB. Stakeholder perception of pharmaceutical value: A multicriteria decision analysis pilot case study for value assessment in the United States. J Manag Care Spec Pharm. 2022 Oct; 28(10):1190-1196.
-
Liu G, Wu EQ, Ahn J, Kamae I, Xie J, Yang H. The Development of Health Technology Assessment in Asia: Current Status and Future Trends. Value Health Reg Issues. 2020 May; 21:39-44.
-
Mulhern B, Norman R, Street DJ, Viney R. One Method, Many Methodological Choices: A Structured Review of Discrete-Choice Experiments for Health State Valuation. Pharmacoeconomics. 2019 01; 37(1):29-43.
-
Ehlers JP, Modi YS, Pecen PE, Goshe J, Dupps WJ, Rachitskaya A, Sharma S, Yuan A, Singh R, Kaiser PK, Reese JL, Calabrise C, Watts A, Srivastava SK. The DISCOVER Study 3-Year Results: Feasibility and Usefulness of Microscope-Integrated Intraoperative OCT during Ophthalmic Surgery. Ophthalmology. 2018 07; 125(7):1014-1027.
-
Ripley B, Levin D, Kelil T, Hermsen JL, Kim S, Maki JH, Wilson GJ. 3D printing from MRI Data: Harnessing strengths and minimizing weaknesses. J Magn Reson Imaging. 2017 03; 45(3):635-645.
-
Dilokthornsakul P, McQueen RB, Chaiyakunapruk N, Spackman E, Watanabe JH, Campbell JD. Value of Information in Asia: Concepts, Current Use, and Future Directions. Value Health Reg Issues. 2016 May; 9:99-104.
-
Bracken JA, Mauti M, Kim MS, Messenger JC, Carroll JD. A Radiation Dose Reduction Technology to Improve Patient Safety During Cardiac Catheterization Interventions. J Interv Cardiol. 2015 Oct; 28(5):493-7.
-
Carroll JD, Shuren J, Jensen TS, Hernandez J, Holmes D, Marinac-Dabic D, Edwards FH, Zuckerman BD, Wood LL, Kuntz RE, Mack MJ. Transcatheter valve therapy registry is a model for medical device innovation and surveillance. Health Aff (Millwood). 2015 Feb; 34(2):328-34.
-
Campbell JD, McQueen RB, Briggs A. The "e" in cost-effectiveness analyses. A case study of omalizumab efficacy and effectiveness for cost-effectiveness analysis evidence. Ann Am Thorac Soc. 2014 Feb; 11 Suppl 2:S105-11.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|